Art Produced by Holocaust Victims

Join Artsbridge for Marc Schimsky’s presentation, "Art Produced by Holocaust Victims - A Focus on the Terezin Four."
 
Buck’s County artist, teacher and activist Marc Schimsky will talk about the covert sketches of ghetto life produced by a group of artists who were imprisoned at the ghetto/camp known as Terezin.
 
Contact Information
  1. Laurie Braman
  2. 908-763-8574
  3. laurie.braman@yahoo.com
Thu, November 16
7:00 pm — 9:00 pm
Add to My Calendar 11/16/2017 7:00pm 11/16/2017 9:00pm America/New_York Art Produced by Holocaust Victims

Join Artsbridge for Marc Schimsky’s presentation, "Art Produced by Holocaust Victims - A Focus on the Terezin Four."

Buck’s County artist, teacher and activist Marc Schimsky will talk about the covert sketches of ghetto life produced by a group of artists who were imprisoned at the ghetto/camp known as Terezin.

33 Risler Street Stockton, NJ 08559

Prallsville Mills

33 Risler Street
Stockton, NJ 08559

Sign Up for E-Calendar

Flemington/Raritan
FILED UNDER

Arts & Entertainment

TAP Into Another Town's News:

TAP Into Another Town's News:

Sign Up for E-Calendar

Flemington/Raritan

AtlantiCast

AtlantiCast: Episode 010

On this week’s AtlantiCast, we take you to the groundbreaking for an expansion to Morristown Medical Center, introduce you to the newest babies of 2018 at Atlantic Health System and share some must-see winter weather tips!

 

'Affordable' Housing Deal Signed Without Public Input

January 16, 2018

To the editor:

Across New Jersey the Fair Share Housing Center – a group of lawyers who make their money building and renting affordable housing – is threatening and suing towns in a blatant attempt to control local zoning. While all towns must fulfill an obligation to provide affordable housing, FSHC has now become the arbiter of “how much” and is ...

Brain Cancer Study Opens at Overlook Medical Center

January 16, 2018

Kurt Jaeckle, MD, co-director of the Gerald J. Glasser Brain Tumor Center at Overlook Medical Center, and medical director of the Atlantic Center for Research, is leading a phase III study of novel drug VAL-083, which has already shown promise in Glioblastoma and other cancers. The study is for patients whose glioblastoma multiforme or gliosarcoma has progressed during or after treatment with the ...